CCG-203971

CCG-203971

CAT N°: 15075
Price:

From 72.00 61.20

Signaling through small G proteins of the RhoA subfamily, including RhoC, induces actin-regulated cytosolic-to-nuclear translocation of the oncogene product megakaryoblastic leukemia 1 (MKL1), which binds to serum response factor (SRF).{15012} The MKL1/SRF complex, in turn, activates the transcription of serum response element (SRE) regulated genes, stimulating cell migration, a process that is central to metastasis.{15012} CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50 = 6.4 ?M), with 87% inhibition of SRE activation achieved at 100 ?M.{25536} This compound also inhibits PC-3 cell migration (IC50 = 4.2 ?M), as determined by a scratch wound assay.{25536} CCG-203971 causes no cytotoxicity when evaluated by WST-1 assay.{25536} It is well tolerated in normal mice up to doses of 100 mg/kg given intraperitoneally over five days.{25536}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • N-(4-chlorophenyl)-1-[3-(2-furanyl)benzoyl]-3-piperidinecarboxamide
  • Correlated keywords
    • CCG203971 SRE serum response element cell migration metastasis PC3 prostate cancer WST1 MKL-1 megakaryoblastic leukemia
  • Product Overview:
    Signaling through small G proteins of the RhoA subfamily, including RhoC, induces actin-regulated cytosolic-to-nuclear translocation of the oncogene product megakaryoblastic leukemia 1 (MKL1), which binds to serum response factor (SRF).{15012} The MKL1/SRF complex, in turn, activates the transcription of serum response element (SRE) regulated genes, stimulating cell migration, a process that is central to metastasis.{15012} CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50 = 6.4 ?M), with 87% inhibition of SRE activation achieved at 100 ?M.{25536} This compound also inhibits PC-3 cell migration (IC50 = 4.2 ?M), as determined by a scratch wound assay.{25536} CCG-203971 causes no cytotoxicity when evaluated by WST-1 assay.{25536} It is well tolerated in normal mice up to doses of 100 mg/kg given intraperitoneally over five days.{25536}

We also advise you